PTGS2 and central nervous system cancer: By preserving glioma cell stemness and the inflammatory milieu, Glioma aggressiveness is increased by COX-2 and its product (PG) E2, which interact with four GPCRs (PGE2 receptors like EP1, EP2, EP3, and EP4) [138].